Alzheimer's Disease Trial, Recruiting (NCT06835283)

Alzheimer's Disease Trial, Recruiting NCT06835283 Sponsor: Baylor College of Medicine Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06835283 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a veteran between the ages of 60 and 85
You have been diagnosed by a doctor with mild to moderate Alzheimer's disease or a related form of dementia
You have noticeable behavioral or mood-related symptoms (such as anxiety, depression, or irritability) that showed up on a specific questionnaire called the Neuropsychiatric Inventory Questionnaire (confirm with trial site)
You scored between 15 and 23 on a standard memory and thinking test called the Mini-Mental State Examination, indicating mild to moderate cognitive impairment (confirm with trial site)
You have a caregiver who is willing and able to take you to and from clinic visits, fill out questionnaires, and help with treatment sessions at home
If you are currently taking any medications that affect mood or mental health, your dose has been stable for at least 4 weeks

Who may not be able to join:

You have a medical reason why you cannot have an MRI scan
You have a condition that prevents you from safely receiving brain stimulation treatments, including (but not limited to) a seizure disorder, severe heart disease, a history of brain surgery, or a stroke in a specific area of the brain (confirm with trial site)
You currently have a problem with alcohol or drug misuse, based on a screening questionnaire (note: nicotine use is allowed, and mild cannabis or alcohol use may also be allowed — confirm with trial site)
Your behavioral or mood symptoms are so severe — especially agitation or aggression — that the treatment could not be delivered safely or effectively
You have another unstable health condition that, in the opinion of the study doctors, could interfere with the treatment or raise the risk of side effects

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 206-419-1261

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06835283

Sponsor: Baylor College of Medicine

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 206-419-1261

More information: https://clinicaltrials.gov/study/NCT06835283

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a veteran between the ages of 60 and 85
You have been diagnosed by a doctor with mild to moderate Alzheimer's disease or a related form of dementia
You have noticeable behavioral or mood-related symptoms (such as anxiety, depression, or irritability) that showed up on a specific questionnaire called the Neuropsychiatric Inventory Questionnaire (confirm with trial site)
You scored between 15 and 23 on a standard memory and thinking test called the Mini-Mental State Examination, indicating mild to moderate cognitive impairment (confirm with trial site)
You have a caregiver who is willing and able to take you to and from clinic visits, fill out questionnaires, and help with treatment sessions at home
If you are currently taking any medications that affect mood or mental health, your dose has been stable for at least 4 weeks

Who may not be able to join:

You have a medical reason why you cannot have an MRI scan
You have a condition that prevents you from safely receiving brain stimulation treatments, including (but not limited to) a seizure disorder, severe heart disease, a history of brain surgery, or a stroke in a specific area of the brain (confirm with trial site)
You currently have a problem with alcohol or drug misuse, based on a screening questionnaire (note: nicotine use is allowed, and mild cannabis or alcohol use may also be allowed — confirm with trial site)
Your behavioral or mood symptoms are so severe — especially agitation or aggression — that the treatment could not be delivered safely or effectively
You have another unstable health condition that, in the opinion of the study doctors, could interfere with the treatment or raise the risk of side effects

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Baylor College of Medicine

Registry

ClinicalTrials.gov

Start date

1 August 2026

Est. completion

1 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of iTBS-tDCS treatment in ADRD patients; Tolerability of iTBS-tDCS treatment in ADRD patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov